Comparison of the analgesic effect of Meloxicam and Ibuprofen on post endodontic pain
Design
Twenty-two patients with irreversible pulp recognition and two lateral tooth (left and right), will be selected .This study is clinical trial and double blind.
Settings and conduct
Twenty-two patients with irreversible pulp recognition and two lateral tooth (left and right), will be selected .This study is clinical trial and double blind.This study is double blind. Researcher who complete questionnaire and analyzer are blind (double blind).Outcome assessor and analyzer don't aware from grouping.The person evaluating the outcome is unaware of the grouping. Groups A and B are available to analyzer and outcome assessor.
Participants/Inclusion and exclusion criteria
Inclusion criteria:Recognize pulpitis irreversible, Both of gender
Exclusion criteria:Lack of cooperation
Intervention groups
We treat patients in Ibuprofen group by 11 tab of Ibuprofen 400 milligram(Aria,Tehran,Iran).
We treat patients in Meloxicam group by 11 tab of Meloxicam 7.5 milligram(Zahravi,Tabriz,Iran).
Main outcome variables
Pain
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20141209020258N109
Registration date:2019-04-27, 1398/02/07
Registration timing:registered_while_recruiting
Last update:2019-04-27, 1398/02/07
Update count:0
Registration date
2019-04-27, 1398/02/07
Registrant information
Name
Fariba Farokhi
Name of organization / entity
Arak University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 86 3222 2003
Email address
f.farokhi@arakmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-01-21, 1397/11/01
Expected recruitment end date
2020-01-21, 1398/11/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the analgesic effect of Meloxicam and Ibuprofen on post endodontic pain
Public title
Comparison of the analgesic effect of Meloxicam and Ibuprofen on post endodontic pai
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Recognize pulpitis irreversible
Both of gender
Exclusion criteria:
Lack of cooperation
Age
From 20 years old
Gender
Both
Phase
2-3
Groups that have been masked
Outcome assessor
Data analyser
Sample size
Target sample size:
22
Randomization (investigator's opinion)
Randomized
Randomization description
Simple individual randomization with random number table in division of groups in two groups A and B.
Randomization method: Simple randomization.
Random unit: Individual.
How to build sequences: First, we set the framework for our statistical society. We started from a table point in a row or column. Given the type of code in the row, we chose the same number of digits. After that, the numbers control the path. We noticed smaller numbers of the statistical community. We have to continue this work so that the number of samples is completed.Even numbers were used for intervention group and odd numbers were used for the control group.
Allocation concealment:Numbered drug containers
Blinding (investigator's opinion)
Double blinded
Blinding description
This study is double blind. Researcher who complete questionnaire and analyzer are blind (double blind).Outcome assessor and analyzer don't aware from grouping.The person evaluating the outcome is unaware of the grouping. Groups A and B are available to analyzer and outcome assessor.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee Arak University Of Medical Sciences